{"id":"W2963547298","doi":"10.1182/blood.v130.suppl_1.3123.3123","title":"Treatment Patterns and Associated Outcomes in Patients with Relapsed or Refractory Multiple Myeloma in the US and Non-US Countries: Findings from Preamble","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Daratumumab; Internal medicine; Observational study; Ixazomib; Multiple myeloma; Family medicine; Bortezomib; Oncology; Carfilzomib","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006454908,0.0002290529,0.000320683,0.001396303,0.0004796732,0.0008310886,0.0005085262,0.0004086475,0.002369587],"category_scores_gemma":[0.002707296,0.0001624668,0.0005575468,0.003714433,0.000307871,0.0005794966,0.000966408,0.000471089,0.0002739143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007477414,"about_ca_system_score_gemma":0.0008620602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02452312,"about_ca_topic_score_gemma":0.0252932,"domain_scores_codex":[0.9993167,0.0001629811,0.0001226157,0.000154724,0.00008971956,0.0001533008],"domain_scores_gemma":[0.9973871,0.0002162373,0.001680971,0.0000908177,0.0002934605,0.0003314236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001297547,0.00002575925,0.9982491,0.000021171,0.00005945107,0.00003039427,0.0001068321,0.00002516157,0.00003064756,0.00002291337,0.0003806979,0.0009182238],"study_design_scores_gemma":[0.00002312555,0.00006733326,0.9981571,0.00004391955,0.000050635,0.0002357205,0.0007169202,0.00009322898,0.0000225573,0.00003355388,0.00055034,0.000005610075],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946597,0.0008178612,0.00003947809,0.0002160903,0.00001004202,0.00001957051,0.003292487,0.000004684071,0.0009399504],"genre_scores_gemma":[0.9976879,0.0002547685,0.00004568474,0.0001331496,0.00001238201,0.00002106833,0.001755195,0.000003296085,0.00008653194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02452312,"threshold_uncertainty_score":0.04876071,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0167735922802384,"score_gpt":0.2749713511974358,"score_spread":0.2581977589171974,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}